Amanote Research

Amanote Research

    RegisterSign In

The Cost-Effectiveness of Biopharmaceuticals

mAbs - United States
doi 10.4161/mabs.4.2.18812
Full Text
Open PDF
Abstract

Available in full text

Categories
AllergyImmunology
Date

March 1, 2012

Authors
Andrew W. WilsonPeter J. Neumann
Publisher

Informa UK Limited


Related search

The Limits of Cost-Effectiveness.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1984English

On the Cost-Effectiveness of Ergonomics

Applied Ergonomics
RiskPhysical TherapyHuman FactorsEngineeringReliabilityErgonomicsSports TherapySafetyQualityRehabilitation
2003English

The Limits of Cost-Effectiveness Analysis

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2009English

Getting the Cost Right in Cost-Effectiveness Analyses

American Journal of Psychiatry
PsychiatryMental Health
1997English

Cost-Effectiveness Analysis

Dental Abstracts
2012English

Cost-Effectiveness Analysis.

BMJ
1993English

Insurance Coverage of Biopharmaceuticals

Health Affairs
MedicineHealth Policy
2006English

Factors Affecting the Cost Effectiveness of Antibiotics

Chemotherapy Research and Practice
2011English

Cost-Effectiveness Analyses

1966English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy